Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Estimated seroprevalence of SARS-CoV-2 antibodies among adults in Orange County, California
Tim A. Bruckner, Daniel M. Parker, Scott M. Bartell, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis
Xinhua Chen, Zhiyuan Chen, Andrew S. Azman, et al.
The Lancet Global Health (2021) Vol. 9, Iss. 5, pp. e598-e609
Open Access | Times Cited: 239
Changes in the Relationship Between Income and Life Expectancy Before and During the COVID-19 Pandemic, California, 2015-2021
Hannes Schwandt, Janet Currie, Till von Wachter, et al.
JAMA (2022) Vol. 328, Iss. 4, pp. 360-360
Open Access | Times Cited: 140
Antibody Responses in COVID-19: A Review
Mateo Chvatal-Medina, Yorjagis Mendez-Cortina, Pablo Javier Patiño Grajales, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 137
Ethnic inequalities in COVID-19 infection, hospitalisation, intensive care admission, and death: a global systematic review and meta-analysis of over 200 million study participants
Patricia Irizar, Daniel Pan, Dharmi Kapadia, et al.
EClinicalMedicine (2023) Vol. 57, pp. 101877-101877
Open Access | Times Cited: 56
Distinct SARS-CoV-2 antibody reactivity patterns elicited by natural infection and mRNA vaccination
Rafael Ramiro de Assis, Aarti Jain, Rie Nakajima, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 70
Serology as a Tool to Assess Infectious Disease Landscapes and Guide Public Health Policy
Andrea Haselbeck, Justin Im, Kristi Prifti, et al.
Pathogens (2022) Vol. 11, Iss. 7, pp. 732-732
Open Access | Times Cited: 34
Semiparametric modeling of SARS-CoV-2 transmission using tests, cases, deaths, and seroprevalence data
Damon Bayer, Isaac Goldstein, Jonathan Fintzi, et al.
The Annals of Applied Statistics (2024) Vol. 18, Iss. 3
Open Access | Times Cited: 6
SARS-CoV-2 Cumulative Incidence and Period Seroprevalence: Results From a Statewide Population-Based Serosurvey in California
Katherine Lamba, Heather Bradley, Kayoko Shioda, et al.
Open Forum Infectious Diseases (2021) Vol. 8, Iss. 8
Open Access | Times Cited: 23
Effect of socioeconomic factors during the early COVID-19 pandemic: a spatial analysis
Ian W. Tang, Verónica M. Vieira, E. J. Shearer
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 16
Distinct SARS-CoV-2 Antibody Responses Elicited by Natural Infection and mRNA Vaccination
Rafael Ramiro de Assis, Aarti Jain, Rie Nakajima, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 22
Orange County, California COVID-19 Vaccine Equity Best Practices Checklist: A Community-Centered Call to Action for Equitable Vaccination Practices
Kameko Washburn, Alana M. W. LeBrón, Abigail Reyes, et al.
Health Equity (2022) Vol. 6, Iss. 1, pp. 3-12
Open Access | Times Cited: 14
Risk factors for SARS-CoV-2 seroprevalence following the first pandemic wave in UK healthcare workers in a large NHS Foundation Trust
Hayley Colton, David Hodgson, Hailey Hornsby, et al.
Wellcome Open Research (2022) Vol. 6, pp. 220-220
Open Access | Times Cited: 14
Community Activation to TrAnsform Local sYSTems (CATALYST): A Qualitative Study Protocol
Alana M. W. LeBrón, Melina Michelen, Brittany N. Morey, et al.
International Journal of Qualitative Methods (2024) Vol. 23
Open Access | Times Cited: 2
SARS-CoV-2 active infection prevalence and seroprevalence in the adult population of St. Louis County
Charles W. Goss, Brett Maricque, Victoria V. Anwuri, et al.
Annals of Epidemiology (2022) Vol. 71, pp. 31-37
Open Access | Times Cited: 11
Risk factors for SARS-CoV-2 seroprevalence following the first pandemic wave in UK healthcare workers in a large NHS Foundation Trust
Hayley Colton, David Hodgson, Hailey Hornsby, et al.
Wellcome Open Research (2021) Vol. 6, pp. 220-220
Open Access | Times Cited: 15
Predictors of Test Positivity, Mortality, and Seropositivity during the Early Coronavirus Disease Epidemic, Orange County, California, USA
Daniel M. Parker, Tim A. Bruckner, Verónica M. Vieira, et al.
Emerging infectious diseases (2021) Vol. 27, Iss. 10, pp. 2604-2618
Open Access | Times Cited: 14
Accounting for assay performance when estimating the temporal dynamics in SARS-CoV-2 seroprevalence in the U.S.
Bernardo García‐Carreras, Matt D. T. Hitchings, Michael A. Johansson, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Recent Shifts in Racial/Ethnic Disparities in COVID-19 Mortality in the Vaccination Period in California
Alicia R. Riley, Mathew V. Kiang, Yea‐Hung Chen, et al.
Journal of General Internal Medicine (2022) Vol. 37, Iss. 7, pp. 1818-1820
Open Access | Times Cited: 9
The Pandemic Experience in Southeast Asia: Interface Between SARS-CoV-2, Malaria, and Dengue
Christina Yek, Vũ Sinh Nam, Rithea Leang, et al.
Frontiers in Tropical Diseases (2021) Vol. 2
Open Access | Times Cited: 12
Understanding COVID-19 Epidemiology and Implications for Control: The Experience from a Greek Semi-Closed Community
Ourania S. Kotsiou, Dimitrios Papagiannis, Εvangelos C. Fradelos, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 13, pp. 2765-2765
Open Access | Times Cited: 11
SARS‐CoV‐2 infection during pregnancy and preterm birth in Massachusetts from March 2020 through March 2021
Anne Marie Darling, Hanna Shephard, Eirini Nestoridi, et al.
Paediatric and Perinatal Epidemiology (2022) Vol. 37, Iss. 2, pp. 93-103
Open Access | Times Cited: 7
SARS-CoV-2 acquisition and immune pathogenesis among school-aged learners in four diverse schools
Dan M. Cooper, Michael Z. Zulu, Allen Jankeel, et al.
Pediatric Research (2021) Vol. 90, Iss. 5, pp. 1073-1080
Open Access | Times Cited: 8
Inferring the COVID-19 infection fatality rate in the community-dwelling population: a simple Bayesian evidence synthesis of seroprevalence study data and imprecise mortality data
Harlan Campbell, Paul Gustafson
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 7
SARS-CoV-2 Period Seroprevalence and Related Factors, Hillsborough County, Florida, USA, October 2020–March 2021
Anna R. Giuliano, Shari Pilon‐Thomas, Michael J. Schell, et al.
Emerging infectious diseases (2022) Vol. 28, Iss. 3, pp. 556-563
Open Access | Times Cited: 5
Risk factors for SARS-CoV-2 seropositivity in a health care worker population during the early pandemic
Sebastian D. Schubl, Cesar Figueroa, Anton M. Palma, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top